Caroline Flament

Villejuif, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies.

RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies.

Journal: Oncoimmunology

Published: January 12, 2023

Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

Journal: Cancer discovery

Published: February 18, 2022

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.

Journal: Cancer discovery

Published: November 03, 2021

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Journal: Cell death and differentiation

Published: January 30, 2021

Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.

Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.

Journal: Nature medicine

Published: August 28, 2019

T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants.

T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 30, 2019

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Journal: Science (New York, N.Y.)

Published: April 05, 2017

Predictors of responses to immune checkpoint blockade in advanced melanoma.

Predictors of responses to immune checkpoint blockade in advanced melanoma.

Journal: Nature communications

Published: February 01, 2017

Chemokine receptors expression on T cells: contribution to diagnosis of melanoma metastasis dissemination status

Chemokine receptors expression on T cells: contribution to diagnosis of melanoma metastasis dissemination status

Journal: Medecine sciences : M/S

Published: September 13, 2016

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

Journal: Science (New York, N.Y.)

Published: July 31, 2015

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

Journal: Immunity

Published: July 27, 2015

Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.

Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.

Journal: The Journal of clinical investigation

Published: November 18, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026